Acute stroke care: A manual from the university of texas-houston stroke team

Acute stroke care: A manual from the university of texas-houston stroke team

Volumn , Issue , 2007, Pages 1-213

  Uchino, Ken ^a   Pary, Jennifer ^b   Grotta, James ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Center for Neurosciences   (United States)

^c University of Texas Medical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 51649102824     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545108     Document Type: Book

References (140)

1. Mohr, J. P., Choi, D., Grotta, J. C., Weir, B., & Wolf, P. Stroke: Pathophysiology, Diagnosis, & Management. 4th edn. Philadelphia, PA: Churchill Livingstone, 2004.
2. Warlow, C. P., Dennis, M. S., van Gijn, J., & Hankey, G. J. Stroke. 2nd edn. Oxford: Blackwell, 2001.
3. Caplan, L. R. Caplan's Stroke: A Clinical Approach. 3rd edn. Boston, MA: Butterworth-Heinemann, 2000.
4. Adams, H. P., Jr., Hachinski, V. & Norris, J. W. Ischemic Cerebrovascular Disease. Contemporary Neurology Series. Oxford: Oxford University Press, 2001.
5. Bogousslavsky, J. and Caplan, L. Stroke Syndromes. 2nd edn. Cambridge: Cambridge University Press, 2001.
6. Bogousslavsky, J. and Caplan, L. Uncommon Causes of Stroke. 2nd edn. Cambridge: Cambridge University Press, 2001.
7. AHA/ASA scientific statement. Guidelines for the early management of patients with ischemic stroke. Stroke 2005; 36: 916-23.
8. ASA scientific statement. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke 1999; 30: 905-15.
9. AHA scientific statement. Guidelines for the management of aneurysmal subarachnoid hemorrhage. Circulation 1994; 90: 2592-605.
10. AHA scientific statement. Recommendations for the management of patients with unruptured intracranial aneurysms. Circulation 2000; 102: 2300-8.
11. European Stroke Initiative recommendations for stroke management: Update 2003. Cerebrovasc. Dis. 2003; 16: 311-37.
12. European Stroke Initiative. Recommendations for stroke management. http://www.eusi-stroke.com/recommendations/rc_overview.shtml.
13. Bates, B., Choi, J. Y., Duncan, P. W., et al. Veterans Affairs/Department of Defense clinical practice guideline for the management of adult stroke rehabilitation care: Executive summary [AHA/ASA-endorsed practice guidelines]. Stroke 2005; 36: 2049-56.
14. Sacco, R. L., Adams, R., Albers, G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006; 37: 577-617.
15. Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. Antithrombotics. Chest 2001; 119: 300S-320S
16. Gorelick, P. B. Stroke prevention therapy beyond antithrombotics: Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. Stroke 2002; 33: 862-75.
17. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 1995; 333: 1581-8.
18. Lyden, P. D. Thrombolytic Therapy for Acute Stroke. 2nd edn. Totowa, NJ: Humana Press, 2005.
19. Qureshi, A. I., Tuhrim, S., Broderick, J. P., Batjer, H. H., Hondo, H.,&Hanley, D. F. Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 2001; 344: 1450-60.
20. Hart, R. G., Halperin, J. L., Pearce, L. A., et al. Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann. Intern. Med. 2003; 138: 831-8.
21. Parizel, P. M., Makkat, S., Van Miert, E., Van Goethem, J. W., van den Hauwe, L., & De Schepper, A. M. Intracranial hemorrhage: Principles of CT and MRI interpretation. Eur. Radiol. 2001; 11: 1770-83.
22. Fleetwood, I. G. & Steinberg, G. K. Arteriovenous malformations. Lancet 2002; 359: 863-73.
23. Van Gijn, J. & Rinkel, G. J. E. Subarachnoid haemorrhage: Diagnosis, causes and managment. Brain 2001; 124: 249-78.
24. Adams, H. P., Jr., Adams, R. J., Brott, T., et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34: 1056-83.
25. Adams, H., Adams, R., Del Zoppo, G., & Goldstein, L. B. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update. A Scientific Statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005; 36: 916-23.
26. International Stroke Trial Collaborative Group. Lancet 1997; 349: 1569-81.
27. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997; 349: 1641-9.
28. Berge, E., Abdelnoor, M., Nakstad, P. H., & Sandset, P. M. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 2000; 355: 1205-10.
29. Hart, R. G., Palacio, S., & Pearce, L. A. Atrial fibrillation, stroke, and acute antithrombotic therapy: Analysis of randomized clinical trials. Stroke 2002; 33: 2722-7.
30. Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. Antithrombotic and thrombolytic therapy for ischemic stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 suppl.): 483S-512S. http://www.chestjournal.org/cgi/reprint/126/3_suppl/483S.
31. Adams, H. P., Jr., Bendixen, B. H., Kappelle, L. J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
32. U-King-Im, J. M., Trivedi, R. A., Graves, M. J., et al. Contrast-enhanced MR angiography for carotid disease: Diagnostic and potential clinical impact. Neurology 2004; 62: 1282-90.
33. Petty, G. W., Brown, R. D., Jr., Whisnant, J. P., Sicks, J. D., O'Fallon, W. M., & Wiebers, D. O. Survival and recurrence after first cerebral infarction: A population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998; 50: 208-16.
34. Hartmann, A., Rundek, T., Mast, H., et al. Mortality and causes of death after first ischemic stroke: The Northern Manhattan Stroke Study. Neurology 2001; 57: 2000-5.
35. Bravata, D. M., Ho, S. Y., Brass, L. M., Concato, J., Scinto, J., & Meehan, T. P. Long-term mortality in cerebrovascular disease. Stroke 2003; 34: 699-704.
36. Dewey, H. M., Sturm, J., Donnan, G. A., Macdonell, R. A., McNeil, J. J., & Thrift, A. G. Incidence and outcome of subtypes of ischaemic stroke: Initial results from the North East Melbourne stroke incidence study (NEMESIS). Cerebrovasc. Dis. 2003; 15: 133-9.
37. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 1995; 333: 1581-7.
38. Marler, J. R., Tilley, B. C., Lu, M., et al. Early stroke treatment associated with better outcome: The NINDS rt-PA stroke study. Neurology 2000; 55: 1649-55.
39. Marler, J. R., Tilley, B. C., Lu, M., et al. Stroke 1997; 28: 2119-25.
40. Patel, S. C., Levine, S. R., Tilley, B. C., et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001; 286: 2830-8.
41. Interventional Management of Stroke Study. Stroke 2004; 35: 904-11.
42. Hacke, W., Donnan, G., Fieschi, C., et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-74.
43. Smith, W. C., Sung, G., Starkman, S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005; 36: 1432-8.
44. Saxena, R., Lewis, S., Berge, E., Sandercock, P. A., & Koudstaal, P. J. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 2001; 32: 2333-7.
45. Kang, D. W., Latour, L. L., Chalela, J. A., Dambrosia, J., & Warach, S. Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann. Neurol. 2003; 54: 66-74.
46. Lovett, J. K., Coull, A. J., & Rothwell, P. M. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62: 569-73.
47. Fiorelli, M., Bastianello, S., von Kummer, R., et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30: 2280-4.
48. Lees, K. R., Zivin, J. A., Ashwood, T., et al. for the Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. NXY-059 for acute ischemic stroke. N. Engl. J. Med. 2006; 354: 588-600.
49. Schneider, L. S., Dagerman, K. S., & Insel, P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 1934-43.
50. Sacco, R. L., Adams, R., Albers, G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006; 37: 577-617.
51. Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
52. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., & Dagenais, G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000; 342: 145-53.
53. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., & Dagenais, G. Lancet 2001; 358: 1033-41.
54. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.
55. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Lancet 2002; 360: 7-22.
56. Grundy, S. M., Cleeman, J. I., Merz, C. N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-39.
57. Toole, J. F., Malinow, M. R., Chambless, L. E., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291: 565-75.
58. Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. A clinical trial of estrogen-replacement therapy after ischemic stroke. N. Engl. J. Med. 2001; 345: 1243-9.
59. Anderson, G. L., Limacher, M., Assaf, A. R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-12.
60. Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
61. Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al. BMJ 1994; 308: 81-106.
62. Diener, H. C., Cunha, L., Forbes, C., Sivenius, J., Smets, P., & Lowenthal, A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J. Neurol. Sci. 1996; 143: 1-13.
63. The ESPS Group. The European Stroke Prevention Study (ESPS): Principal end-points. Lancet 1987; 2: 1351-4.
64. Caprie. Lancet 1996; 348: 1329-39.
65. Diener, H. C., Bogousslavsky, J., Brass, L. M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331-7.
66. Bhatt, D. L., Fox, K. A. A., Hacke, W., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N. Engl. J. Med. 2006; 354: 1706-17.
67. Hart, R. G., Halperin, J. L., Pearce, L. A., et al. Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann. Intern. Med. 2003; 138: 831-8.
68. Saxena, R. & Koudstaal, P. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst. Rev. 2004(4): CD000187.
69. Ferro, J. M. Cardioembolic stroke: An update. Lancet Neurol. 2003; 2: 177-88.
70. Amarenco, P., Cohen, A., Tzourio, C., et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N. Engl. J. Med. 1994; 331: 1474-9.
71. Blackshear, J. L., Zabalgoitia, M., Pennock, G., et al. Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiography. Am. J. Cardiol. 1999; 83: 453-5, A9.
72. Mohr, J. P. Anticoagulation for stroke prevention: Yes, no, maybe. Cleve. Clin. J. Med. 2004; 71 (Suppl. 1): S52-6.
73. Homma, S., Sacco, R. L., Di Tullio, M. R., Sciacca, R. R., & Mohr, J. P. Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625-31.
74. Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N. Engl. J. Med. 2005; 352: 1305-16.
75. Mohr, J. P., Thompson, J. L., Lazar, R. M., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N. Engl. J. Med. 2001; 345: 1444-51.
76. Levine, S. R., Brey, R. L., Tilley, B. C., et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576-84.
77. Chobanian, A. V., Bakris, G. L., Black, H. R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-72.
78. Dahlof, B., Devereux, R. B., Kjeldsen, S. E., et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 2002; 359: 995-1003.
79. Psaty, B. M., Lumley, T., Furberg, C. D., et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis. JAMA 2003; 289: 2534-44.
80. Barnett, H. J. Decision-making for carotid endarterectomy: The trials are only the start. Can. J. Neurol. Sci. 2002; 29: 302-4.
81. Barnett, H. J., Taylor, D. W., Eliasziw, M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Engl. J. Med. 1998; 339: 1415-25.
82. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421-8.
83. Halliday, A., Mansfield, A., Marro, J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 2004; 363: 1491-502.
84. Yadav, J. S., Wholey, M. H., Kuntz, R. E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N. Engl. J. Med. 2004; 351: 1493-501.
85. Rothwell, P. M., Eliasziw, M., Gutnikov, S. A., Warlow, C. P., & Barnett, H. J. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915-24.
86. Rothwell, P. M., Eliasziw, M., Gutnikov, S. A., Warlow, C. P., & Barnett, H. J. Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004; 35: 2855-61.
87. Bond, R., Rerkasem, K., & Rothwell, P. M. Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke 2003; 34: 2290-301.
88. Grubb, R. L., Jr., Powers, W. J., Derdeyn, C. P., Adams, H. P., Jr., & Clarke, W. R. The carotid occlusion surgery study. Neurosurg. Focus 2003; 14 (3): 9.
89. Grubb, R. L., Jr., Derdeyn, C. P., Fritsch, S. M., et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998; 280: 1055-60.
90. Vernieri, F., Pasqualetti, P., Passarelli, F., Rossini, P. M., & Silvestrini, M. Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke 1999; 30: 593-8.
91. Yonemura, K., Kimura, K., Minematsu, K., Uchino, M., & Yamaguchi, T. Small centrum ovale infarcts on diffusion-weighted magnetic resonance imaging. Stroke 2002; 33: 1541-1544.
92. Landau, W. M. Clinical neuromythology VI. Au clair de lacune: Holy, wholly, holey logic. Neurology 1989; 39: 725-30.
93. Perry, H. M., Jr., Davis, B. R., Price, T. R., et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: The Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000; 284: 465-71.
94. Chen, C. J., Tseng, Y. C., Lee, T. H., Hsu, H. L., & See, L. C. Multisection CT angiography compared with catheter angiography in diagnosing vertebral artery dissection. AJNR Am. J. Neuroradiol. 2004; 25: 769-74.
95. Touze, E., Gauvrit, J. Y., Moulin, T., Meder, J. F., Bracard, S., & Mas, J. L. Risk of stroke and recurrent dissection after a cervical artery dissection: A multicenter study. Neurology 2003; 61: 1347-51.
96. Overell, J. R., Bone, I., & Lees, K. R. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000; 55: 1172-9.
97. Messe, S. R., Silverman, I. E., Kizer, J. R., et al. Practice parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62: 1042-50.
98. Albers, G. W., Caplan, L. R., Easton, J. D., et al. Transient ischemic attack: Proposal for a new definition. N. Engl. J. Med. 2002; 347: 1713-16.
99. Johnston, S. C., Gress, D. R., Browner, W. S., & Sidney, S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284: 2901-6.
100. Johnston, S. C. & Sidney, S. Validation of a 4-point prediction rule to stratify short-term stroke risk after TIA [abstract]. Stroke 2005; 36: 430. [Presentation, International Stroke Meeting, February 2006.]
101. Qureshi, A. I., Tuhrim, S., Broderick, J. P., Batjer, H. H., Hondo, H., & Hanley, D. F. Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 2001; 344: 1450-60.
102. Mendelow, A. D., Gregson, B. A., Fernandes, H. M., et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): A randomised trial. Lancet 2005; 365: 387-97.
103. Broderick, J. P., Adams, H. P., Jr., Barsan, W., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30: 905-15.
104. Brott, T., Broderick, J., Kothari, R., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1-5.
105. Mayer, S. A., Brun, N. C., Begtrup, K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. 2005; 352: 777-85.
106. Broderick, J. P., Brott, T. G., Duldner, J. E., Tomsick, T., & Huster, G. Volume of intracerebral hemorrhage: A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987-93.
107. Hemphill, J. C., Bonovich, D. C., Besmertis, L., Manley, G. T., & Johnston, S. C. The ICH score: A simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32: 891-7.
108. Mayberg, M. R., Batjer, H. H., Dacey, R. et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: 2315-28.
109. Molyneux, A., Kerr, R., Stratton, I., et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: A randomised trial. Lancet 2002; 360: 1267-74.
110. Van Den Bergh, W. M., Algra, A., van Kooten, F., et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: A randomized controlled trial. Stroke 2005; 36: 1011-15.
111. Longstreth, W. T., Jr., Nelson, L. M., Koepsell, T. D., & van Belle, G. Clinical course of spontaneous subarachnoid hemorrhage: A population-based study in King County, Washington. Neurology 1993; 43: 712-18.
112. Kassell, N. F., Torner, J. C., Jane, J. A., Haley, E. C., Jr., & Adams, H. P. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J. Neurosurg. 1990; 73: 37-47.
113. Kassell, N. F., Torner, J. C., Jane, J. A., Haley, E. C., Jr., & Adams, H. P. N. Engl. J. Med. 1998; 339: 1725-33.
114. Wiebers, D. O., Whisnant, J. P., Huston, J., et al. Unruptured intracranial aneurysms: Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003; 362: 103-10.
115. Brainin, M., Olsen, T. S., Chamorro, A., et al. Organization of stroke care: Education, referral, emergency management and imaging, stroke units and rehabilitation. European Stroke Initiative. Cerebrovasc. Dis. 2004; 17 (Suppl. 2): 1-14.
116. Hack, W., Kaste, M., Bogousslavsky, J., et al. European Stroke Initiative Recommendations for Stroke Management: Update 2003. Cerebrovasc. Dis. 2003; 16: 311-37.
117. Schwamm, L. H., Pancioli, A., Acker, J. E., et al. Recommendations for the establishment of stroke systems of care: Recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke 2005; 36: 690-703.
118. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst. Rev. 2002 (1): CD000197.
119. Alberts, M. J., Hademenos, G., Latchaw, R. E., et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000; 283: 3102-9.
120. Duncan, P. W., Zorowitz, R., Bates, B., et al. Management of adult stroke rehabilitation care: A clinical practice guideline. Stroke 2005; 36: E100-43.
121. Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N. Engl. J. Med. 2000; 343: 180-4.
122. Kay, J., Chow, W. H., Chan, T. M., et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA 2003; 289: 553-8.
123. Merten, G. J., Burgess, W. P., Gray, L. V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 2004; 291: 2328-34.
124. Barber, P. A., Demchuk, A. M., Zhang, J., & Buchan, A. M. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000; 355: 1670-4.
125. Eastwood, J. D., Engelter, S. T., MacFall, J. F., Delong, D. M., & Provenzale, J. M. Quantitative assessment of the time course of infarct signal intensity on diffusion-weighted images. AJNR Am. J. Neuroradiol. 2003; 24: 680-7.
126. Parizel, P. M., Makkat, S., Van Miert, E., Van Goethem, J. W., van den Hauwe, L., & De Schepper, A. M. Intracranial hemorrhage: Principles of CT and MRI interpretation. Eur. Radiol. 2001; 11: 1770-83.
127. Alexandrov, A. V. Cerebrovascular Ultrasound in Stroke Prevention and Treatment: Elmsford, NY; Oxford: Blackwell/Futura, 2004.
128. Angeli, S., Del Sette, M., Beelke, M., Anzola, G. P., & Zanette, E. Transcranial Doppler in the diagnosis of cardiac patent foramen ovale. Neurol. Sci. 2001; 22: 353-6.
129. Jauss, M. & Zanette, E. Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc. Dis. 2000; 10: 490-6.
130. Toth, C. & Voll, C. Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke. Stroke 2002; 33: 670-4.
131. Hillbom, M., Erila, T., Sotaniemi, K., Tatlisumak, T., Sarna, S., & Kaste, M. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: A randomized, double-blind study. Acta Neurol. Scand. 2002; 106: 84-92.
132. Hillbom, M., Erila, T., Sotaniemi, K., Tatlisumak, T., Sarna, S., & Kaste, M. JAMA 1968; 205: 337-40.
133. Teasdale, G. & Jennett, B. Assessment of coma and impaired consciousness: A practical scale. Lancet 1974; 2: 81-4.
134. Hunt, W. E. & Hess, R. M. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J. Neurosurg. 1968; 28: 14-20.
135. Teasdale, G. M., Drake, C. G., Hunt, W., et al. A universal subarachnoid hemorrhage scale: Report of a committee of the World Federation of Neurosurgical Societies. J. Neurol. Neurosurg. Psychiatry 1988; 51: 1457.
136. Rankin, J. Cerebral vascular accidents in patients over the age of 60. Scott. Med. J. 1957; 2: 200-15.
137. Bonita, R. & Beaglehole, R. Modification of Rankin scale: Recovery of motor function after stroke. Stroke 1988; 19: 1497-500.
138. Van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & Van Gijn, J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-7.
139. Goldstein, L. B., Bertels, C., & Davis, J. N. Interrater reliability of the NIH stroke scale. Arch. Neurol. 1989; 46: 660-2.
140. Lyden, P., Raman, R., Liu, L., et al. NIHSS training and certification using a new digital video disk is reliable. Stroke 2005; 36: 2446-9.